New Mexico Regulator Moves Toward Ban of Albuterol: BloodHorse 1/28/19

BloodHorse Staff: Believing improper use of albuterol has gone up since clenbuterol was banned from racing in the state, the New Mexico Racing Commission is moving toward a ban of albuterol. The NMRC Rules and Medication Committee voted Jan. 16 to make albuterol a "zero tolerance" drug in the state, in both Quarter Horse and

NYSGC Adopts Modified Claiming Rule: BloodHorse 1/28/19

By: Tom Precious Regulators in New York have approved new flexibility in Thoroughbred claiming race rules, though they ordered some last-minute conditions as a bow to the restrictions the same regulators put in place after a high number of equine deaths at the 2012 Aqueduct winter meet. The new rule adopted by the New York

New Program for Racing Investigators to be Launched: Bloodhorse 1/28/19

Press Release: Beginning in the third quarter of 2019, the Association of Racing Commissioners International (ARCI) and the University of Arizona's Racetrack Industry Program (RTIP) will launch an educational program for horse racing investigators employed by racing commissions and tracks. No such program currently exists, and the effort will complement the work of the Organization

ARCI Publishes New Regulatory Standards: Bloodhorse 1/23/19

ARCI Press Release: New racing regulatory standards have just been published by the Association of Racing Commissioners International (ARCI) as part of a continuing process to adapt standards to current integrity threats as well as new technologies and innovation. The standards are embodied in the almost 500 pages of the ARCI's Model Rules of Racing

Racehorse doping prevention and identification focus of three research studies: Horsetalk 1/14/19

Press Release: Tackling the use of illicit substances in the horse world has advanced in recent month with three “tactical research” studies by the Racing Medication and Testing Consortium (RMTC). Tactical research studies focus on detecting, identifying and inhibiting the use of illicit substances. The first study to be published, L-and D-threo Ethylphenidate Concentrations, Pharmacokinetics and Pharmacodynamics in

Koriner fined $3,000 for medication overage: Daily Racing Form 1/2/19

By: Steve Andersen ARCADIA, Calif. – Trainer Brian Koriner has been fined $3,000 for a medication overage detected in one of his runners after a victory at Del Mar last August. In a stipulated agreement with the California Horse Racing Board, Koriner was fined and suspended for 30 days, but the suspension was stayed if

USEF: Horses Can Compete on Pergolide With Therapeutic Use Exemption: The Horse 11/29/18

Press Release: Pergolide has been the mainstay treatment of pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, for several decades. Due to the class of drug that pergolide represents, it is a prohibited substance under Fédération Equestre Internationale and United States Equestrian Federation (USEF) rules. Currently, under USEF GR411, “Conditions For Therapeutic Administrations

Minnesota Settles Three High-Level Post-Race Positives: Bloodhorse 12/20/18

By: Frank Angst The Minnesota Racing Commission has reached settlements to resolve three high-level positives found in recent equine post-race drug tests. Two of the positives were for pemoline (Cylert), and one was for cardarine—both substances that call for the highest level of sanctions according to industry standards. The MRC cited mitigating circumstances as the

Class 1A and 2A Positives at Canterbury: TDN December 17, 2018

By: T.D. Thornton Positive post-race tests for Class 1A and 2A prohibited substances at Canterbury Park have resulted in $2,500 fines and 90-day suspensions for two trainers. The penalties imposed upon Ray E. Tracy Jr. and Judd William Becker could have been doubled. But their $5,000 fines/180-day suspensions were halved as the result of a

Privacy Policy Ok